Wednesday, July 8, 2026

pharma · Osteoarthritis · Pain

Mundipharma

Mundipharma trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Sydney, AU HQ
1952 Founded
2,082 Employees
TGA registrant Type
Company details
Status
Public
HQ
Sydney, AU
Founded
1952
Employees
2,082
Programs
4
Drugs
23
Patents
0
Intelligence · Clinical Trials

Mundipharma clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Mundipharma programs — each row shows trial ID, program name, phase, status, and indication.

Mundipharma trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Mundipharma.

  1. CD101.IV.3.08 — Phase 3

    Clinical update
  2. Oxycodone (OxyNorm®) Injection — Phase 1

    Clinical update
  3. REZZAYO 200 mg powder for concentrate for solution for infusion — Phase 2

    Clinical update
  4. Buprenorphine transdermal patch — Approved

    Clinical update

Trial registry

4 studies